Effectiveness of Recombinant Herpes Zoster Vaccine in the U.S. Medicare Population, 2018 to 2019, by Immunocompetence and Prior Receipt of Live Zoster Vaccine
Effectiveness of Recombinant Herpes Zoster Vaccine in the U.S. Medicare Population, 2018 to 2019, by Immunocompetence and Prior Receipt of Live Zoster Vaccine
Sylvia Becker‐Dreps, Jennifer L. Lund, Nadja A. Vielot, Til Stürmer et al.
Citations
1 citations
Journal
Annals of Internal Medicine
Topics
Herpesvirus Infections and Treatments
Field-Weighted Citation Impact (FWCI)
1.35
article
Effectiveness of Recombinant Herpes Zoster Vaccine in the U.S. Medicare Population, 2018 to 2019, by Immunocompetence and Prior Receipt of Live Zoster Vaccine
Sylvia Becker‐Dreps, Jennifer L. Lund, Nadja A. Vielot, Til Stürmer, Michele Jönsson Funk, Jonathan Fix, David Jay Weber
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Annals of Internal MedicineVol. 178(12)
Institutions
University of North Carolina at Chapel Hill (US), Novavax (United States) (US)